Navigation Links
CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
Date:5/15/2008

that represent global analysis of current sponsor and CRO practices. The 2008 edition features more than 90 completely new charts analyzing the clinical research industry along with updates for hundreds of charts and tables that have become a requirement for industry executives, market researchers, and analysts.

To purchase your copy of State of the Clinical Trials Industry 2008 at the introductory rate of $549 (+ s/h), regular $699 (Special offer of $549 through May 30). Call us at 800-765-9647 or visit our online bookstore at http://www.centerwatch.com.

Corporate licenses are available. For more information, contact us at sales@centerwatch.com or 866-219-3440, ext. 4.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for professionals and patients. A Boston-based publishing and information services company focusing on the clinical research industry, CenterWatch is a business of Jobson Medical Information, LLC. CenterWatch provides proprietary data and information about clinical trials through a variety of publications, databases and information services used by pharmaceutical and biotech companies, CROs, SMOs and investigative sites involved in all aspects of clinical trials.

As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish information about active clinical trials that could be accessed by patients and their advocates. Today, CenterWatch has one of the largest databases of clinical trials actively recruiting patients on the Internet. For more information about CenterWatch's publications and services, please visit http://www.centerwatch.com.


'/>"/>
SOURCE CenterWatch
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
2. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
3. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
4. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
6. Immunosyn Corporation Releases SF-1019 Study Results
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...ublished in ,The Lancet, and Presented at ESC Cong...lts from a new international,study, the GISSI Hear... of,omega-3 acid ethyl esters reduced all cause mo... reasons in patients with chronic heart,failure. T...version of ,The,Lancet, and were presented at the ...
(Date:9/4/2008)...itzerland, September 4 /- Axentis Pha... assess the safety and tolerability,of a new thera...monary,infection in cystic fibrosis patients. The ...agent to be delivered directly to the site of,infe... effects of two,different doses of the new drug. I...
(Date:9/4/2008)...cements Remain on Schedule with Two Abstracts Acce... Release in November 2008, BRIDGEWATER, N.J., Sep...., a specialty pharmaceutical company focused on t...se, today announced the appointment of,Peter L. Ga..., Peter Garrambone,s career includes more than 50...
(Date:9/3/2008)... College of Rheumatology Research and Education Fo...ficant Advances in Detecting, ...- For the first time during its,unpre...arthritis, the,American College of Rheumatology Re...nformation acquired from research funded by the Wi...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3ImaRx Therapeutics Transitions Business Strategy 1285 1ImaRx Therapeutics Transitions Business Strategy 1285 2ImaRx Therapeutics Transitions Business Strategy 1285 3ImaRx Therapeutics Transitions Business Strategy 1285 4ImaRx Therapeutics Transitions Business Strategy 1285 5EMH Regional Medical Center Selects TransUnions Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 10446 1EMH Regional Medical Center Selects TransUnions Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 10446 2EMH Regional Medical Center Selects TransUnions Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 10446 3Topspin Medical Announces First Commercial Installation of the Cathamaran 28TM 29 Intravascular MRI System 2840 1Topspin Medical Announces First Commercial Installation of the Cathamaran 28TM 29 Intravascular MRI System 2840 2Topspin Medical Announces First Commercial Installation of the Cathamaran 28TM 29 Intravascular MRI System 2840 3Asthma Foundation Announces 2008 Asthma Capitals Knoxville on Top Again 10440 1Asthma Foundation Announces 2008 Asthma Capitals Knoxville on Top Again 10440 2Asthma Foundation Announces 2008 Asthma Capitals Knoxville on Top Again 10440 3
...May 31, 2007 - Hemispherx Biopharma, Inc.,(AMEX: H...inical,development and manufacture of new drug ent...y a new scientific report featuring,its antiviral ...ting highly pathogenic avian influenza (HPAI), als...xperimental oral formulation,of the Company,s Alfe...
...ESS WIRE)--May 30, 2007 - People with a,class of r...age,coma and death can be successfully treated wi...sity School of Medicine and Lucile,Packard Childre...ecedented 25-year study that,prompt diagnosis coup... significantly improves the survival rates of peop...
Other Medicine Technology:Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 2Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 3Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 4Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 2Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 3Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 4
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...unique public-private partnership in healthcare, t...ll ensure medical care for the poor that will be p... The Sarva Swasthya Mission Trust is the brainchi...as roped in major investors to provide funds. He h...
...ia become a "near-epidemic" in the Dooars region o...re than 20,000 persons in the past two and a half ...y.// Nirmal Das, an MLA from Alipurduar constitue...at 48 deaths had been reported from Alipurduar sub...
...n biotech major Biocon Ltd has roped in Bayer Heal...ugen in the Chinese market, the company //said in ...h firm plans to launch Insugen in China by 2007-08...stration trials and seeking the regulatory approva...
...aldomero Olivera said that the ruthless fish-eatin... back pain.// He is planning to present his findi...snails, with their striking patterns and elegant s...tching shells on display and for sale at the annua...
Other Medicine News:Health News:Bayer to Market Biocon Insulin in China 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: